nodes	percent_of_prediction	percent_of_DWPC	metapath
Ganciclovir—SLC22A1—Progesterone—uterine cancer	0.416	1	CbGbCtD
Ganciclovir—Dehydration—Doxorubicin—uterine cancer	0.000346	0.000592	CcSEcCtD
Ganciclovir—Thrombocytopenia—Etoposide—uterine cancer	0.000345	0.000591	CcSEcCtD
Ganciclovir—Tachycardia—Etoposide—uterine cancer	0.000344	0.000589	CcSEcCtD
Ganciclovir—Eosinophilia—Epirubicin—uterine cancer	0.000344	0.000589	CcSEcCtD
Ganciclovir—Liver function test abnormal—Doxorubicin—uterine cancer	0.000344	0.000588	CcSEcCtD
Ganciclovir—Skin disorder—Etoposide—uterine cancer	0.000343	0.000586	CcSEcCtD
Ganciclovir—Dry skin—Doxorubicin—uterine cancer	0.000341	0.000584	CcSEcCtD
Ganciclovir—Hyperhidrosis—Etoposide—uterine cancer	0.000341	0.000584	CcSEcCtD
Ganciclovir—Pancreatitis—Epirubicin—uterine cancer	0.000341	0.000583	CcSEcCtD
Ganciclovir—Hypokalaemia—Doxorubicin—uterine cancer	0.000339	0.00058	CcSEcCtD
Ganciclovir—Anorexia—Etoposide—uterine cancer	0.000336	0.000575	CcSEcCtD
Ganciclovir—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000335	0.000574	CcSEcCtD
Ganciclovir—Diarrhoea—Dactinomycin—uterine cancer	0.000333	0.000571	CcSEcCtD
Ganciclovir—Nasopharyngitis—Doxorubicin—uterine cancer	0.000333	0.00057	CcSEcCtD
Ganciclovir—Pancytopenia—Epirubicin—uterine cancer	0.00033	0.000565	CcSEcCtD
Ganciclovir—Hypotension—Etoposide—uterine cancer	0.00033	0.000564	CcSEcCtD
Ganciclovir—Gastritis—Doxorubicin—uterine cancer	0.000329	0.000564	CcSEcCtD
Ganciclovir—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000328	0.000562	CcSEcCtD
Ganciclovir—Muscular weakness—Doxorubicin—uterine cancer	0.000328	0.000562	CcSEcCtD
Ganciclovir—Neutropenia—Epirubicin—uterine cancer	0.000325	0.000556	CcSEcCtD
Ganciclovir—Dysuria—Epirubicin—uterine cancer	0.000325	0.000556	CcSEcCtD
Ganciclovir—Abdominal distension—Doxorubicin—uterine cancer	0.000324	0.000554	CcSEcCtD
Ganciclovir—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000323	0.000553	CcSEcCtD
Ganciclovir—Dysphagia—Doxorubicin—uterine cancer	0.000322	0.000551	CcSEcCtD
Ganciclovir—Pollakiuria—Epirubicin—uterine cancer	0.000321	0.00055	CcSEcCtD
Ganciclovir—Eosinophilia—Doxorubicin—uterine cancer	0.000318	0.000545	CcSEcCtD
Ganciclovir—Photosensitivity reaction—Epirubicin—uterine cancer	0.000317	0.000543	CcSEcCtD
Ganciclovir—Paraesthesia—Etoposide—uterine cancer	0.000317	0.000542	CcSEcCtD
Ganciclovir—Pancreatitis—Doxorubicin—uterine cancer	0.000315	0.00054	CcSEcCtD
Ganciclovir—Weight decreased—Epirubicin—uterine cancer	0.000314	0.000538	CcSEcCtD
Ganciclovir—Dyspnoea—Etoposide—uterine cancer	0.000314	0.000538	CcSEcCtD
Ganciclovir—Hyperglycaemia—Epirubicin—uterine cancer	0.000314	0.000537	CcSEcCtD
Ganciclovir—Somnolence—Etoposide—uterine cancer	0.000313	0.000537	CcSEcCtD
Ganciclovir—Pneumonia—Epirubicin—uterine cancer	0.000312	0.000534	CcSEcCtD
Ganciclovir—Infestation NOS—Epirubicin—uterine cancer	0.00031	0.000531	CcSEcCtD
Ganciclovir—Infestation—Epirubicin—uterine cancer	0.00031	0.000531	CcSEcCtD
Ganciclovir—Vomiting—Dactinomycin—uterine cancer	0.00031	0.00053	CcSEcCtD
Ganciclovir—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000307	0.000526	CcSEcCtD
Ganciclovir—Rash—Dactinomycin—uterine cancer	0.000307	0.000526	CcSEcCtD
Ganciclovir—Decreased appetite—Etoposide—uterine cancer	0.000307	0.000525	CcSEcCtD
Ganciclovir—Pancytopenia—Doxorubicin—uterine cancer	0.000305	0.000523	CcSEcCtD
Ganciclovir—Renal failure—Epirubicin—uterine cancer	0.000305	0.000522	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Etoposide—uterine cancer	0.000304	0.000521	CcSEcCtD
Ganciclovir—Fatigue—Etoposide—uterine cancer	0.000304	0.00052	CcSEcCtD
Ganciclovir—Neuropathy peripheral—Epirubicin—uterine cancer	0.000304	0.00052	CcSEcCtD
Ganciclovir—Stomatitis—Epirubicin—uterine cancer	0.000302	0.000517	CcSEcCtD
Ganciclovir—Jaundice—Epirubicin—uterine cancer	0.000302	0.000517	CcSEcCtD
Ganciclovir—Pain—Etoposide—uterine cancer	0.000302	0.000516	CcSEcCtD
Ganciclovir—Constipation—Etoposide—uterine cancer	0.000302	0.000516	CcSEcCtD
Ganciclovir—Urinary tract infection—Epirubicin—uterine cancer	0.000301	0.000516	CcSEcCtD
Ganciclovir—Conjunctivitis—Epirubicin—uterine cancer	0.000301	0.000516	CcSEcCtD
Ganciclovir—Dysuria—Doxorubicin—uterine cancer	0.000301	0.000515	CcSEcCtD
Ganciclovir—Neutropenia—Doxorubicin—uterine cancer	0.000301	0.000515	CcSEcCtD
Ganciclovir—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000299	0.000512	CcSEcCtD
Ganciclovir—Sweating—Epirubicin—uterine cancer	0.000297	0.000509	CcSEcCtD
Ganciclovir—Pollakiuria—Doxorubicin—uterine cancer	0.000297	0.000509	CcSEcCtD
Ganciclovir—Haematuria—Epirubicin—uterine cancer	0.000296	0.000506	CcSEcCtD
Ganciclovir—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000294	0.000503	CcSEcCtD
Ganciclovir—Hepatobiliary disease—Epirubicin—uterine cancer	0.000293	0.000502	CcSEcCtD
Ganciclovir—Weight decreased—Doxorubicin—uterine cancer	0.000291	0.000498	CcSEcCtD
Ganciclovir—Feeling abnormal—Etoposide—uterine cancer	0.000291	0.000497	CcSEcCtD
Ganciclovir—Hyperglycaemia—Doxorubicin—uterine cancer	0.00029	0.000497	CcSEcCtD
Ganciclovir—Nausea—Dactinomycin—uterine cancer	0.000289	0.000495	CcSEcCtD
Ganciclovir—Agranulocytosis—Epirubicin—uterine cancer	0.000289	0.000495	CcSEcCtD
Ganciclovir—Pneumonia—Doxorubicin—uterine cancer	0.000288	0.000494	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Etoposide—uterine cancer	0.000288	0.000494	CcSEcCtD
Ganciclovir—Infestation NOS—Doxorubicin—uterine cancer	0.000287	0.000491	CcSEcCtD
Ganciclovir—Infestation—Doxorubicin—uterine cancer	0.000287	0.000491	CcSEcCtD
Ganciclovir—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000284	0.000487	CcSEcCtD
Ganciclovir—Renal failure—Doxorubicin—uterine cancer	0.000282	0.000483	CcSEcCtD
Ganciclovir—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000281	0.000481	CcSEcCtD
Ganciclovir—Urticaria—Etoposide—uterine cancer	0.00028	0.00048	CcSEcCtD
Ganciclovir—Haemoglobin—Epirubicin—uterine cancer	0.00028	0.000479	CcSEcCtD
Ganciclovir—Jaundice—Doxorubicin—uterine cancer	0.00028	0.000478	CcSEcCtD
Ganciclovir—Stomatitis—Doxorubicin—uterine cancer	0.00028	0.000478	CcSEcCtD
Ganciclovir—Rhinitis—Epirubicin—uterine cancer	0.000279	0.000477	CcSEcCtD
Ganciclovir—Abdominal pain—Etoposide—uterine cancer	0.000279	0.000477	CcSEcCtD
Ganciclovir—Body temperature increased—Etoposide—uterine cancer	0.000279	0.000477	CcSEcCtD
Ganciclovir—Urinary tract infection—Doxorubicin—uterine cancer	0.000279	0.000477	CcSEcCtD
Ganciclovir—Conjunctivitis—Doxorubicin—uterine cancer	0.000279	0.000477	CcSEcCtD
Ganciclovir—Haemorrhage—Epirubicin—uterine cancer	0.000278	0.000476	CcSEcCtD
Ganciclovir—Hepatitis—Epirubicin—uterine cancer	0.000278	0.000476	CcSEcCtD
Ganciclovir—Hypoaesthesia—Epirubicin—uterine cancer	0.000277	0.000474	CcSEcCtD
Ganciclovir—Pharyngitis—Epirubicin—uterine cancer	0.000276	0.000473	CcSEcCtD
Ganciclovir—Sweating—Doxorubicin—uterine cancer	0.000275	0.000471	CcSEcCtD
Ganciclovir—Urinary tract disorder—Epirubicin—uterine cancer	0.000275	0.00047	CcSEcCtD
Ganciclovir—Oedema peripheral—Epirubicin—uterine cancer	0.000274	0.000469	CcSEcCtD
Ganciclovir—Haematuria—Doxorubicin—uterine cancer	0.000273	0.000468	CcSEcCtD
Ganciclovir—Connective tissue disorder—Epirubicin—uterine cancer	0.000273	0.000468	CcSEcCtD
Ganciclovir—Urethral disorder—Epirubicin—uterine cancer	0.000273	0.000467	CcSEcCtD
Ganciclovir—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000271	0.000464	CcSEcCtD
Ganciclovir—Visual impairment—Epirubicin—uterine cancer	0.000268	0.000459	CcSEcCtD
Ganciclovir—Agranulocytosis—Doxorubicin—uterine cancer	0.000268	0.000458	CcSEcCtD
Ganciclovir—Erythema multiforme—Epirubicin—uterine cancer	0.000263	0.00045	CcSEcCtD
Ganciclovir—Hypersensitivity—Etoposide—uterine cancer	0.00026	0.000445	CcSEcCtD
Ganciclovir—Tinnitus—Epirubicin—uterine cancer	0.000259	0.000444	CcSEcCtD
Ganciclovir—Haemoglobin—Doxorubicin—uterine cancer	0.000259	0.000443	CcSEcCtD
Ganciclovir—Rhinitis—Doxorubicin—uterine cancer	0.000258	0.000442	CcSEcCtD
Ganciclovir—Haemorrhage—Doxorubicin—uterine cancer	0.000257	0.000441	CcSEcCtD
Ganciclovir—Hepatitis—Doxorubicin—uterine cancer	0.000257	0.000441	CcSEcCtD
Ganciclovir—Hypoaesthesia—Doxorubicin—uterine cancer	0.000256	0.000438	CcSEcCtD
Ganciclovir—Pharyngitis—Doxorubicin—uterine cancer	0.000256	0.000437	CcSEcCtD
Ganciclovir—Urinary tract disorder—Doxorubicin—uterine cancer	0.000254	0.000435	CcSEcCtD
Ganciclovir—Oedema peripheral—Doxorubicin—uterine cancer	0.000254	0.000434	CcSEcCtD
Ganciclovir—Asthenia—Etoposide—uterine cancer	0.000253	0.000433	CcSEcCtD
Ganciclovir—Connective tissue disorder—Doxorubicin—uterine cancer	0.000253	0.000433	CcSEcCtD
Ganciclovir—Angiopathy—Epirubicin—uterine cancer	0.000252	0.000432	CcSEcCtD
Ganciclovir—Urethral disorder—Doxorubicin—uterine cancer	0.000252	0.000432	CcSEcCtD
Ganciclovir—Mediastinal disorder—Epirubicin—uterine cancer	0.000251	0.000429	CcSEcCtD
Ganciclovir—Chills—Epirubicin—uterine cancer	0.00025	0.000427	CcSEcCtD
Ganciclovir—Pruritus—Etoposide—uterine cancer	0.000249	0.000427	CcSEcCtD
Ganciclovir—Arrhythmia—Epirubicin—uterine cancer	0.000249	0.000425	CcSEcCtD
Ganciclovir—Visual impairment—Doxorubicin—uterine cancer	0.000248	0.000425	CcSEcCtD
Ganciclovir—Alopecia—Epirubicin—uterine cancer	0.000246	0.000421	CcSEcCtD
Ganciclovir—Mental disorder—Epirubicin—uterine cancer	0.000244	0.000417	CcSEcCtD
Ganciclovir—Erythema multiforme—Doxorubicin—uterine cancer	0.000243	0.000417	CcSEcCtD
Ganciclovir—Malnutrition—Epirubicin—uterine cancer	0.000242	0.000415	CcSEcCtD
Ganciclovir—Diarrhoea—Etoposide—uterine cancer	0.000241	0.000413	CcSEcCtD
Ganciclovir—Tinnitus—Doxorubicin—uterine cancer	0.00024	0.000411	CcSEcCtD
Ganciclovir—Flatulence—Epirubicin—uterine cancer	0.000239	0.000409	CcSEcCtD
Ganciclovir—Tension—Epirubicin—uterine cancer	0.000238	0.000407	CcSEcCtD
Ganciclovir—Dysgeusia—Epirubicin—uterine cancer	0.000237	0.000406	CcSEcCtD
Ganciclovir—Nervousness—Epirubicin—uterine cancer	0.000235	0.000403	CcSEcCtD
Ganciclovir—Back pain—Epirubicin—uterine cancer	0.000234	0.000401	CcSEcCtD
Ganciclovir—Angiopathy—Doxorubicin—uterine cancer	0.000234	0.0004	CcSEcCtD
Ganciclovir—Dizziness—Etoposide—uterine cancer	0.000233	0.000399	CcSEcCtD
Ganciclovir—Muscle spasms—Epirubicin—uterine cancer	0.000233	0.000399	CcSEcCtD
Ganciclovir—Mediastinal disorder—Doxorubicin—uterine cancer	0.000232	0.000397	CcSEcCtD
Ganciclovir—Chills—Doxorubicin—uterine cancer	0.000231	0.000395	CcSEcCtD
Ganciclovir—Arrhythmia—Doxorubicin—uterine cancer	0.00023	0.000394	CcSEcCtD
Ganciclovir—Vision blurred—Epirubicin—uterine cancer	0.000228	0.000391	CcSEcCtD
Ganciclovir—Alopecia—Doxorubicin—uterine cancer	0.000227	0.000389	CcSEcCtD
Ganciclovir—Mental disorder—Doxorubicin—uterine cancer	0.000226	0.000386	CcSEcCtD
Ganciclovir—Ill-defined disorder—Epirubicin—uterine cancer	0.000225	0.000385	CcSEcCtD
Ganciclovir—Vomiting—Etoposide—uterine cancer	0.000224	0.000384	CcSEcCtD
Ganciclovir—Malnutrition—Doxorubicin—uterine cancer	0.000224	0.000384	CcSEcCtD
Ganciclovir—Anaemia—Epirubicin—uterine cancer	0.000224	0.000383	CcSEcCtD
Ganciclovir—Agitation—Epirubicin—uterine cancer	0.000223	0.000381	CcSEcCtD
Ganciclovir—Rash—Etoposide—uterine cancer	0.000222	0.000381	CcSEcCtD
Ganciclovir—Dermatitis—Etoposide—uterine cancer	0.000222	0.00038	CcSEcCtD
Ganciclovir—Headache—Etoposide—uterine cancer	0.000221	0.000378	CcSEcCtD
Ganciclovir—Flatulence—Doxorubicin—uterine cancer	0.000221	0.000378	CcSEcCtD
Ganciclovir—Tension—Doxorubicin—uterine cancer	0.00022	0.000376	CcSEcCtD
Ganciclovir—Dysgeusia—Doxorubicin—uterine cancer	0.000219	0.000376	CcSEcCtD
Ganciclovir—Malaise—Epirubicin—uterine cancer	0.000218	0.000374	CcSEcCtD
Ganciclovir—Nervousness—Doxorubicin—uterine cancer	0.000218	0.000373	CcSEcCtD
Ganciclovir—Vertigo—Epirubicin—uterine cancer	0.000218	0.000372	CcSEcCtD
Ganciclovir—Leukopenia—Epirubicin—uterine cancer	0.000217	0.000371	CcSEcCtD
Ganciclovir—Back pain—Doxorubicin—uterine cancer	0.000217	0.000371	CcSEcCtD
Ganciclovir—Muscle spasms—Doxorubicin—uterine cancer	0.000215	0.000369	CcSEcCtD
Ganciclovir—Cough—Epirubicin—uterine cancer	0.000211	0.000362	CcSEcCtD
Ganciclovir—Vision blurred—Doxorubicin—uterine cancer	0.000211	0.000362	CcSEcCtD
Ganciclovir—Convulsion—Epirubicin—uterine cancer	0.00021	0.000359	CcSEcCtD
Ganciclovir—Nausea—Etoposide—uterine cancer	0.000209	0.000359	CcSEcCtD
Ganciclovir—Hypertension—Epirubicin—uterine cancer	0.000209	0.000358	CcSEcCtD
Ganciclovir—Ill-defined disorder—Doxorubicin—uterine cancer	0.000208	0.000356	CcSEcCtD
Ganciclovir—Anaemia—Doxorubicin—uterine cancer	0.000207	0.000355	CcSEcCtD
Ganciclovir—Chest pain—Epirubicin—uterine cancer	0.000206	0.000353	CcSEcCtD
Ganciclovir—Arthralgia—Epirubicin—uterine cancer	0.000206	0.000353	CcSEcCtD
Ganciclovir—Myalgia—Epirubicin—uterine cancer	0.000206	0.000353	CcSEcCtD
Ganciclovir—Agitation—Doxorubicin—uterine cancer	0.000206	0.000353	CcSEcCtD
Ganciclovir—Anxiety—Epirubicin—uterine cancer	0.000205	0.000352	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000205	0.000351	CcSEcCtD
Ganciclovir—Discomfort—Epirubicin—uterine cancer	0.000204	0.000349	CcSEcCtD
Ganciclovir—Malaise—Doxorubicin—uterine cancer	0.000202	0.000346	CcSEcCtD
Ganciclovir—Dry mouth—Epirubicin—uterine cancer	0.000202	0.000345	CcSEcCtD
Ganciclovir—Vertigo—Doxorubicin—uterine cancer	0.000201	0.000345	CcSEcCtD
Ganciclovir—Leukopenia—Doxorubicin—uterine cancer	0.000201	0.000343	CcSEcCtD
Ganciclovir—Confusional state—Epirubicin—uterine cancer	0.000199	0.000341	CcSEcCtD
Ganciclovir—Anaphylactic shock—Epirubicin—uterine cancer	0.000198	0.000338	CcSEcCtD
Ganciclovir—Oedema—Epirubicin—uterine cancer	0.000198	0.000338	CcSEcCtD
Ganciclovir—Infection—Epirubicin—uterine cancer	0.000196	0.000336	CcSEcCtD
Ganciclovir—Cough—Doxorubicin—uterine cancer	0.000196	0.000335	CcSEcCtD
Ganciclovir—Convulsion—Doxorubicin—uterine cancer	0.000194	0.000332	CcSEcCtD
Ganciclovir—Thrombocytopenia—Epirubicin—uterine cancer	0.000194	0.000331	CcSEcCtD
Ganciclovir—Hypertension—Doxorubicin—uterine cancer	0.000193	0.000331	CcSEcCtD
Ganciclovir—Tachycardia—Epirubicin—uterine cancer	0.000193	0.00033	CcSEcCtD
Ganciclovir—Skin disorder—Epirubicin—uterine cancer	0.000192	0.000329	CcSEcCtD
Ganciclovir—Hyperhidrosis—Epirubicin—uterine cancer	0.000191	0.000327	CcSEcCtD
Ganciclovir—Myalgia—Doxorubicin—uterine cancer	0.000191	0.000327	CcSEcCtD
Ganciclovir—Chest pain—Doxorubicin—uterine cancer	0.000191	0.000327	CcSEcCtD
Ganciclovir—Arthralgia—Doxorubicin—uterine cancer	0.000191	0.000327	CcSEcCtD
Ganciclovir—Anxiety—Doxorubicin—uterine cancer	0.00019	0.000325	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000189	0.000324	CcSEcCtD
Ganciclovir—Discomfort—Doxorubicin—uterine cancer	0.000189	0.000323	CcSEcCtD
Ganciclovir—Anorexia—Epirubicin—uterine cancer	0.000188	0.000323	CcSEcCtD
Ganciclovir—Dry mouth—Doxorubicin—uterine cancer	0.000187	0.000319	CcSEcCtD
Ganciclovir—Hypotension—Epirubicin—uterine cancer	0.000185	0.000316	CcSEcCtD
Ganciclovir—Confusional state—Doxorubicin—uterine cancer	0.000184	0.000316	CcSEcCtD
Ganciclovir—Anaphylactic shock—Doxorubicin—uterine cancer	0.000183	0.000313	CcSEcCtD
Ganciclovir—Oedema—Doxorubicin—uterine cancer	0.000183	0.000313	CcSEcCtD
Ganciclovir—Infection—Doxorubicin—uterine cancer	0.000182	0.000311	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00018	0.000308	CcSEcCtD
Ganciclovir—Thrombocytopenia—Doxorubicin—uterine cancer	0.000179	0.000307	CcSEcCtD
Ganciclovir—Insomnia—Epirubicin—uterine cancer	0.000179	0.000306	CcSEcCtD
Ganciclovir—Tachycardia—Doxorubicin—uterine cancer	0.000179	0.000306	CcSEcCtD
Ganciclovir—Skin disorder—Doxorubicin—uterine cancer	0.000178	0.000304	CcSEcCtD
Ganciclovir—Paraesthesia—Epirubicin—uterine cancer	0.000177	0.000304	CcSEcCtD
Ganciclovir—Hyperhidrosis—Doxorubicin—uterine cancer	0.000177	0.000303	CcSEcCtD
Ganciclovir—Dyspnoea—Epirubicin—uterine cancer	0.000176	0.000302	CcSEcCtD
Ganciclovir—Somnolence—Epirubicin—uterine cancer	0.000176	0.000301	CcSEcCtD
Ganciclovir—Anorexia—Doxorubicin—uterine cancer	0.000174	0.000298	CcSEcCtD
Ganciclovir—Dyspepsia—Epirubicin—uterine cancer	0.000174	0.000298	CcSEcCtD
Ganciclovir—Decreased appetite—Epirubicin—uterine cancer	0.000172	0.000294	CcSEcCtD
Ganciclovir—Hypotension—Doxorubicin—uterine cancer	0.000171	0.000293	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000171	0.000292	CcSEcCtD
Ganciclovir—Fatigue—Epirubicin—uterine cancer	0.00017	0.000292	CcSEcCtD
Ganciclovir—Pain—Epirubicin—uterine cancer	0.000169	0.000289	CcSEcCtD
Ganciclovir—Constipation—Epirubicin—uterine cancer	0.000169	0.000289	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000167	0.000285	CcSEcCtD
Ganciclovir—Insomnia—Doxorubicin—uterine cancer	0.000165	0.000283	CcSEcCtD
Ganciclovir—Paraesthesia—Doxorubicin—uterine cancer	0.000164	0.000281	CcSEcCtD
Ganciclovir—Dyspnoea—Doxorubicin—uterine cancer	0.000163	0.000279	CcSEcCtD
Ganciclovir—Feeling abnormal—Epirubicin—uterine cancer	0.000163	0.000279	CcSEcCtD
Ganciclovir—Somnolence—Doxorubicin—uterine cancer	0.000163	0.000278	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Epirubicin—uterine cancer	0.000162	0.000277	CcSEcCtD
Ganciclovir—Dyspepsia—Doxorubicin—uterine cancer	0.000161	0.000276	CcSEcCtD
Ganciclovir—Decreased appetite—Doxorubicin—uterine cancer	0.000159	0.000272	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000158	0.00027	CcSEcCtD
Ganciclovir—Fatigue—Doxorubicin—uterine cancer	0.000158	0.00027	CcSEcCtD
Ganciclovir—Urticaria—Epirubicin—uterine cancer	0.000157	0.000269	CcSEcCtD
Ganciclovir—Pain—Doxorubicin—uterine cancer	0.000156	0.000268	CcSEcCtD
Ganciclovir—Constipation—Doxorubicin—uterine cancer	0.000156	0.000268	CcSEcCtD
Ganciclovir—Abdominal pain—Epirubicin—uterine cancer	0.000156	0.000267	CcSEcCtD
Ganciclovir—Body temperature increased—Epirubicin—uterine cancer	0.000156	0.000267	CcSEcCtD
Ganciclovir—Feeling abnormal—Doxorubicin—uterine cancer	0.000151	0.000258	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00015	0.000256	CcSEcCtD
Ganciclovir—Hypersensitivity—Epirubicin—uterine cancer	0.000146	0.000249	CcSEcCtD
Ganciclovir—Urticaria—Doxorubicin—uterine cancer	0.000145	0.000249	CcSEcCtD
Ganciclovir—Abdominal pain—Doxorubicin—uterine cancer	0.000145	0.000247	CcSEcCtD
Ganciclovir—Body temperature increased—Doxorubicin—uterine cancer	0.000145	0.000247	CcSEcCtD
Ganciclovir—Asthenia—Epirubicin—uterine cancer	0.000142	0.000243	CcSEcCtD
Ganciclovir—Pruritus—Epirubicin—uterine cancer	0.00014	0.000239	CcSEcCtD
Ganciclovir—Diarrhoea—Epirubicin—uterine cancer	0.000135	0.000232	CcSEcCtD
Ganciclovir—Hypersensitivity—Doxorubicin—uterine cancer	0.000135	0.000231	CcSEcCtD
Ganciclovir—Asthenia—Doxorubicin—uterine cancer	0.000131	0.000225	CcSEcCtD
Ganciclovir—Dizziness—Epirubicin—uterine cancer	0.000131	0.000224	CcSEcCtD
Ganciclovir—Pruritus—Doxorubicin—uterine cancer	0.000129	0.000222	CcSEcCtD
Ganciclovir—Vomiting—Epirubicin—uterine cancer	0.000126	0.000215	CcSEcCtD
Ganciclovir—Diarrhoea—Doxorubicin—uterine cancer	0.000125	0.000214	CcSEcCtD
Ganciclovir—Rash—Epirubicin—uterine cancer	0.000125	0.000213	CcSEcCtD
Ganciclovir—Dermatitis—Epirubicin—uterine cancer	0.000125	0.000213	CcSEcCtD
Ganciclovir—Headache—Epirubicin—uterine cancer	0.000124	0.000212	CcSEcCtD
Ganciclovir—Dizziness—Doxorubicin—uterine cancer	0.000121	0.000207	CcSEcCtD
Ganciclovir—Nausea—Epirubicin—uterine cancer	0.000117	0.000201	CcSEcCtD
Ganciclovir—Vomiting—Doxorubicin—uterine cancer	0.000116	0.000199	CcSEcCtD
Ganciclovir—Rash—Doxorubicin—uterine cancer	0.000115	0.000197	CcSEcCtD
Ganciclovir—Dermatitis—Doxorubicin—uterine cancer	0.000115	0.000197	CcSEcCtD
Ganciclovir—Headache—Doxorubicin—uterine cancer	0.000115	0.000196	CcSEcCtD
Ganciclovir—Nausea—Doxorubicin—uterine cancer	0.000109	0.000186	CcSEcCtD
